4.7 Article

Specific tracking of monoamine oxidase A in heart failure models by a far-red fluorescent probe with an ultra large Stokes shift

Journal

CHINESE CHEMICAL LETTERS
Volume 33, Issue 3, Pages 1572-1576

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2021.08.114

Keywords

Heart failure; Monoamine oxidase A; Oxidative stress; Fluorescent probe; Far-red emission; Diagnosis

Funding

  1. National Natural Science Foundation of China [220370 02, 220 07032, 21977082]
  2. National Mega-project for Innovative Drugs of China [2019ZX09721001-004-003]
  3. Chinese Postdoctoral Science Foundation, China [2019M660083]
  4. Shanghai Sailing Program, China [20YF1411200]

Ask authors/readers for more resources

This study successfully developed two fluorescent turn-on probes (KXS-M1 and KXS-M2) for the highly selective and sensitive detection of monoamine oxidase A (MAO-A). Among them, KXS-M2 exhibited better fluorescence increment and sensitivity, and can be used for the diagnosis and treatment of heart failure.
Monoamine oxidase A (MAO-A) is a prominent myocardial source of reactive oxygen species (ROS), and its expression and activity are strongly increased in failing hearts. Therefore, accurate evaluation of MAO-A activity in cardiomyocytes is of great importance for understanding its biological functions and early diagnosing the progression of heart failure. However, so far, there is no report on the fluorescent diagnosis of heart failure by a specific probe for MAO-A. In this work, two far-red emissive fluorescent turn-on probes (KXS-M1 and KXS-M2) for the highly selective and sensitive detection of MAO-A were fabricated. Both probes exhibit good response to MAO-A, one of which, KXS-M2, performs better than the other one in terms of a fluorescence increment and sensitivity. Using the pioneering probe KXS-M2, specific fluorescence imaging of MAO-A in glucose-deprived H9c2 cardiac cells, zebrafish and isoprenaline-induced failing heart tissues was achieved, proving that KXS-M2 can serve as a powerful tool for the diagnosis and treatment of heart failure. (C) 2021 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available